The health profile of the Norwegian Lundehund is dominated by the gastrointestinal complex known as Lundehund syndrome, a constellation of related digestive disorders that affects the breed at rates far exceeding any other dog breed. This syndrome encompasses intestinal lymphangiectasia, protein-losing enteropathy, inflammatory bowel disease, and chronic atrophic gastritis. Estimates suggest that a significant majority of Lundehunds will develop some degree of intestinal disease during their lifetime, though severity varies enormously from subclinical cases with no visible symptoms to severe, life-threatening episodes requiring intensive veterinary intervention. The condition results from the breed's extreme genetic bottleneck, with the entire modern population descending from approximately five or six closely related dogs that survived the population collapse of the 1960s.
Lundehund syndrome manifests through chronic or intermittent diarrhea, vomiting, weight loss, poor coat condition, lethargy, and in severe cases, edema and ascites from protein loss. The most insidious aspect of the condition is its ability to remain subclinical for years before presenting suddenly with severe symptoms. A Lundehund can appear perfectly healthy while its serum albumin levels gradually decline, with the first visible signs appearing only when the disease has progressed significantly. This makes regular veterinary monitoring with blood work including serum albumin measurements essential for all Lundehunds, regardless of apparent health status. A mutation in the LEPREL1 gene has been identified as a contributing factor, and genetic testing through services like Embark is available to identify affected and carrier dogs.
There is currently no cure for Lundehund syndrome, but the condition can be managed in many dogs through careful dietary and medical intervention. A low-fat, high-protein diet with easily digestible ingredients has shown positive effects on gastrointestinal health in affected dogs. Avoiding sudden food changes is critically important, as dietary disruptions can trigger acute episodes. Some dogs require ongoing medical management including corticosteroids, antibiotics for secondary small intestinal bacterial overgrowth, and nutritional supplementation. The prognosis varies widely depending on the severity and the dog's individual response to management protocols. Many dogs with well-managed Lundehund syndrome live relatively normal, comfortable lives, while others experience repeated acute episodes that significantly impact quality of life.
Beyond Lundehund syndrome, the breed may be affected by patellar luxation, follicular dysplasia, and eye conditions. Patellar luxation occurs at moderate frequency and ranges from mild intermittent slipping to persistent displacement requiring surgical correction. Follicular dysplasia affects coat quality and can produce patchy hair loss. These conditions, while worth monitoring, are secondary concerns relative to the gastrointestinal issues that define the breed's health landscape. The Norwegian Kennel Club's outcross program, which introduces genetic material from related breeds like the Norwegian Buhund through carefully planned crosses, represents the most significant long-term effort to address the Lundehund's health challenges by widening the breed's dangerously narrow gene pool.
Common Health Issues
- Lundehund syndrome (intestinal lymphangiectasia / protein-losing enteropathy) - A breed-defining gastrointestinal disorder encompassing intestinal lymphangiectasia, protein-losing enteropathy, and inflammatory bowel disease. A significant majority of Lundehunds will develop some degree of intestinal disease during their lifetime, ranging from subclinical to severe and life-threatening. The condition results in chronic diarrhea, vomiting, weight loss, edema, and ascites due to the inability to properly absorb nutrients and protein from food. A mutation in the LEPREL1 gene has been identified as a contributing factor, and genetic testing is available.
- Chronic atrophic gastritis - Frequently occurs alongside Lundehund syndrome and involves progressive thinning and inflammation of the stomach lining, leading to reduced digestive capacity and nutrient absorption. Dogs with this condition may show intermittent vomiting, appetite changes, and gradual weight loss that can be difficult to distinguish from other gastrointestinal issues without endoscopic evaluation.
- Gastric carcinoma - Lundehunds with chronic atrophic gastritis face an elevated risk of developing gastric neoplasms, including carcinoma. The progression from chronic gastritis to neoplasia can occur over years, making regular veterinary monitoring of gastrointestinal health essential for early detection. This risk is directly linked to the breed's predisposition to chronic stomach inflammation.
- Small intestinal bacterial overgrowth (SIBO) - An overpopulation of bacteria in the small intestine that disrupts normal digestion and nutrient absorption, frequently occurring as a component of or alongside Lundehund syndrome. Symptoms include chronic diarrhea, flatulence, and poor coat condition. Management typically involves dietary modification and intermittent antibiotic therapy under veterinary supervision.
- Patellar luxation - Displacement of the kneecap from its normal groove, ranging from occasional intermittent slipping to persistent dislocation causing lameness. The condition occurs at moderate frequency in the breed and can be evaluated through veterinary orthopedic examination. Severe cases may require surgical correction to restore normal joint function.
- Follicular dysplasia - An inherited coat disorder affecting the normal growth cycle of hair follicles, resulting in patchy hair loss, poor coat quality, and sometimes secondary skin infections. The condition is not life-threatening but requires veterinary dermatological management and may affect the dog's appearance throughout its life.
Preventive Care & Health Monitoring
- LEPREL1 genetic test for Lundehund syndrome - Request documentation from the breeder showing the genetic status of both parents for the LEPREL1 mutation associated with intestinal lymphangiectasia. While the condition affects the breed at high rates regardless of genetic status, knowing carrier status helps breeders make informed decisions and prepares owners for proactive management.
- Regular serum albumin and total protein monitoring - Routine blood work measuring serum albumin levels should be performed at least twice yearly, even in asymptomatic dogs, because Lundehund syndrome can be subclinical for years before suddenly presenting with severe symptoms. Early detection of declining protein levels allows dietary and medical intervention before clinical signs become severe.
- Low-fat, high-protein dietary management - A diet low in fat and higher in easily digestible protein has demonstrated significant positive effects on gastrointestinal health in this breed. Avoid abrupt food changes, which can trigger acute episodes of intestinal distress. Work with a veterinarian experienced in Lundehund gastrointestinal disease to establish an appropriate feeding protocol.
- Patellar luxation evaluation - Veterinary orthopedic examination of the kneecaps should be performed to identify any degree of luxation. Early detection allows for appropriate exercise modification and monitoring to prevent progression.
- Regular paw and extra toe maintenance - The breed's polydactyl feet require regular attention to ensure all six toes on each foot are trimmed properly, as the extra toes may not wear down naturally through normal activity. Interdigital areas should be kept clean and dry to prevent infections, particularly in wet or muddy conditions.
- Connect with breed club veterinary resources - The Norwegian Lundehund Association of America and international Lundehund breed clubs maintain lists of veterinarians experienced with Lundehund syndrome and breed-specific health management. Given the breed's rarity and unique health profile, establishing a relationship with a veterinarian familiar with the breed's specific needs is strongly recommended.